a company for cancer & autoimmune treatment
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CBBIX | 6.95 | 0.03 | +0.43% |
AB Relative Value I | |||
DSGCX | 17.43 | N/A | N/A |
BNY Mellon Select Managers Sm Cp Gr C | |||
SCAYX | 10.68 | -0.05 | -0.47% |
Invesco Income Advantage U.S. Fund Y | |||
FEQMX | 38.37 | -0.24 | -0.62% |
Fidelity Advisor Emerging Markets M | |||
AGGWX | 12.03 | -0.37 | -2.98% |
American Century Global Gold R |
A.I.dvisor indicates that over the last year, ZYME has been loosely correlated with RXRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYME jumps, then RXRX could also see price increases.
Ticker / NAME | Correlation To ZYME | 1D Price Change % | ||
---|---|---|---|---|
ZYME | 100% | +2.12% | ||
RXRX - ZYME | 43% Loosely correlated | +3.07% | ||
XNCR - ZYME | 42% Loosely correlated | +4.16% | ||
ABSI - ZYME | 41% Loosely correlated | +3.79% | ||
BEAM - ZYME | 41% Loosely correlated | +7.82% | ||
VIR - ZYME | 40% Loosely correlated | +5.50% | ||
More |